Skip to content

Effectiveness of a Stress Ball Exercise on Vincristine-Induced Peripheral Neuropathy, Motor Function, and Activities of Daily Living among Children with Acute Lymphoblastic Leukemia Undergoing Chemotherapy: A Randomized Controlled Trial

Effectiveness of a Stress Ball Exercise on Vincristine-Induced Peripheral Neuropathy, Motor Function, and Activities of Daily Living among Children with Acute Lymphoblastic Leukemia Undergoing Chemotherapy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260710010
Enrollment
44
Registered
2026-07-10
Start date
2026-02-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Lymphoblastic Leukemia Vincristine Induced Peripheral Neuropathy Motor Function Impairment Activities of Daily Living Limitation Acute Lymphoblastic Leukemia Vincristine Induced Peripheral Neuropathy

Interventions

Participants received a structured stress ball exercise program in addition to usual care.,Participants received usual care according to the hospital standard protocol without the stress ball exercise
Stress Ball Exercise,Usual Care

Sponsors

Faculty of Nursing, Universitas Indonesia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. Children diagnosed with B cell or T cell Acute Lymphoblastic Leukemia ALL 2. Received a cumulative vincristine dose of at least 6 mg per m2 3. Inpatients or outpatients with stable clinical conditions and age appropriate vital signs within normal limits 4. Able to understand and follow study instructions 5. Written informed consent obtained from parents or legal guardians and child assent when appropriate

Exclusion criteria

Exclusion criteria: 1. Peripheral neuropathy caused by conditions other than chemotherapy such as diabetes mellitus neurological disorders or nerve injury 2. Severe cardiovascular pulmonary neurological musculoskeletal cognitive or emotional disorders that may interfere with participation in the intervention or outcome assessments 3. Any medical condition judged by the investigator to make participation unsafe or affect study outcomes

Design outcomes

Primary

MeasureTime frame
Vincristine induced peripheral neuropathy Baseline before intervention and 4 weeks after intervention Pediatric Chemotherapy Induced Neuropathy (PCIN)

Secondary

MeasureTime frame
Motor function Baseline before intervention and 4 weeks after intervention Timed Up and Go (TUG), Hand Grip Strength, Nine Hole Peg Test (NHPT),Activities of daily living Baseline before intervention and 4 weeks after intervention Modified Barthel Index

Countries

Indonesia

Contacts

Public ContactDesti Muslimah

Faculty of Nursing Universitas Indonesia

destielza@gmail.com085377613898

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026